Infant botulism

Annali dell'Istituto Superiore di Sanita

Volumn 45, Issue 2, 2009, Pages 134-146

  Fenicia, Lucia ^a   Anniballi, Fabrizio ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

Botulinum antitoxin; Botulinum toxin; Botulism; Infant botulism; Rare diseases

Indexed keywords

ARTICLE; BACTERIAL SPORE; BOTULISM; CLOSTRIDIUM; DIFFERENTIAL DIAGNOSIS; HUMAN; INFANT; MICROBIOLOGY; NEWBORN; PATHOLOGY; PRESCHOOL CHILD;

BOTULISM; CHILD, PRESCHOOL; CLOSTRIDIUM; DIAGNOSIS, DIFFERENTIAL; HUMANS; INFANT; INFANT, NEWBORN; SPORES, BACTERIAL;

EID: 69249188396     PISSN: 00212571     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (106)

1. Simpson LL. Molecular pharmacology of botulinum toxin and tetanus toxin. Annu Rev Pharmacol Toxicol 1986; 26: 427-53.
2. Arnon SS. Botulism as an intestinal toxemia. In: Blasser MJ, Smith PD, Radvin JI, Greemberg HB, Guerrant RL (Ed). Infections of the gastrointestinal tract. New York: Raven Press; 1995. p. 257-71.
3. Sobel J. Botulism. Clin Infect Dis 2005; 41: 1167-73.
4. Midura TF, Arnon SS. Infant botulism. Identification of Clostridium botulinum and its toxins in faeces. Lancet 1976; 2: 934-6.
5. Pickett J, Berg B, Chaplin E, Brunstetter-Shafer MA. Syndrome of botulism in infancy: Clinical and electrophysiologic study. N Engl J Med 1976; 295: 770-2.
6. Arnon SS. Infant botulism. In: Fergin RD, Cherry JD, Demmler GJ, Kaplan SL (ed). textbook of pediatric infectious diseases. Philadelphia: Saunders WB; 2004. p. 1758-66.
7. Hatheway CL. Clostridium botulinum and other clostridia that produce botulinum neurotoxins. In: Hauschild AHW, Dodds KL (Ed). Clostridium botulinum: Ecology and control in food. New York: Marcel Dekker Inc.; 1992. p. 3-20.
8. Gimenez DF, Ciccarelli AS. Another type of Clostridium botulinum. Zentralbl Bakteriol [Orig] 1970; 215: 221-4.
9. Sonnabend O, Sonnabend W, Heinzle R, Sigrist T, Dirnhofer R, Krech U. Isolation of Clostridium botulinum type G and identification of type G botulinal toxin in humans: report of five sudden unexpected deaths. J Infect Dis 1981; 143: 22-7.
10. Suen JC, Hatheway CL, Steigerwalt AG, Brenner DC. Argentinense, sp. Nov. a genetically homogeneous group composed for all strains of Clostridium botulinum type G and some non toxigenic strains previously identified as Clostridium subterminale or Clostridium hastiforme. Int J Syst Bacteriol 1988; 38: 375-81.
11. Hauschild AHW. Epidemiology of human foodborne botulism. In: Hauschild AHW, Dodds KL (Ed). Clostridium botulinum: Ecology and control in food. New York: Marcel Dekker Inc.; 1992. p. 69-104.
12. Koepke R, Sobel J, Arnon SS. Global occurrence of infant botulism, 1976-2006. Pediatrics 2008; 122: e73-82.
13. Hall JD, Mccroskey LM, Pincomb BJ, Hatheway CL. Isolation of an organism resembling Clostridium baratii which produces type F botulinal toxin from an infant with botulism. J Clin Microbiol 1985; 21: 654-5.
14. Mccroskey LM, Hatheway CL, Fenicia L, Pasolini B, Aureli P. Characterization of an organism that produces type E botulinal toxin but which resembles Clostridium butyricum from the feces of an infant with type E botulism. J Clin Microbiol 1986; 23: 201-2.
15. th Annual Interagency Botulism Research Coordinating Committee (IBRCC) Meeting. Philadelphia-USA, 14-18 September 2008; HB-1.
16. Barash JR, Tang TW, Arnon SS. First case of infant botulism caused by Clostridium baratii type F in California. J Clin Microbiol 2005; 43: 4280-2.
17. Trethon A, Budai J, Herendi A, Szabo V, Geczy M. Botulism in infancy. Orv Hetil 1995; 136: 1497-9.
18. Gupta A, Sumner CJ, Castor M, Maslanka S, Sobel J. Adult botulism type F in the United States, 1981-2002. Neurology 2005; 65: 1694-700.
19. Harvey SM, Sturgeon J, Dassey DE. Botulism due to Clostridium baratii type F toxin. J Clin Microbiol 2002; 40: 2260-2.
20. Aureli P, Fenicia L, Pasolini B, Gianfranceschi M, Mccroskey LM, Hatheway CL. Two cases of type E infant botulism caused by neurotoxigenic Clostridium butyricum in Italy. J Infect Dis 1986; 154: 207-11.
21. Fenicia L, Anniballi F, Aureli P. Intestinal toxemia botulism in Italy, 1984-2005. Eur J Clin Microbiol Infect Dis 2007; 26: 385-94.
22. Fenicia L, Franciosa G, Pourshaban M, Aureli P. Intestinal toxemia botulism in two young people, caused by Clostridium butyricum type E. Clin Infect Dis 1999; 29: 1381-7.
23. Schechter R, Arnon SS. Commentary: where Marco Polo meets Meckel: type E botulism from Clostridium butyricum. Clin Infect Dis 1999; 29: 1388-93.
24. Abe Y, Negasawa T, Monma C, Oka A. Infantile botulism caused by Clostridium butyricum type e toxin. Pediatr Neurol 2008; 38: 55-7.
25. th Annual Interagency Botulism Research Coordinating Committee (IBRCC) Meeting. Philadelphia, USA, 14-18 September 2008. p. 45.
26. Meng X, Karasawa T, Zou K, Kuang X, Wang X, Lu C, Wang C, Yamakawa K, Nakamura S. Characterization of a neurotoxigenic Clostridium butyricum strain isolated from the food implicated in an outbreak of food-borne type E botulism. J Clin Microbiol 1997; 35: 2160-2.
27. Chaudhry R, Dhawan B, Kumar D, Bhatia R, Gandhi JC, Patel RK, Purohit BC. Outbreak of suspected Clostridium butyricum botulism in India. Emerg Infect Dis 1998; 4: 506-7.
28. Anniballi F, Fenicia L, Franciosa G, Aureli P. Infuence of pH and temperature on the growth of and toxin production by neurotoxigenic strains of Clostridium butyricum type E. J Food Prot 2002; 65: 1267-70.
29. Meng X, Yamakawa K, Zou K, Wang X, Kuang X, Lu C, Wang C, Karasawa T, Nakamura S. Isolation and characterisation of neurotoxigenic Clostridium butyricum from soil in China. J Med Microbiol 1999; 48: 133-7.
30. Hauschild AHW. Clostridium botulinum. In: Doyle MP (Ed). Ecology and control in food. New York and Basel: Marcel Dekker, Inc.; 1989. p. 111-89.
31. Dodds KL. Clostridium botulinum in the environment. In: Hauschild aHW, Dodds KL (Ed). Clostridium botulinum: Ecology and control in food. New York: Marcel Dekker Inc.; 1992. p. 21-53.
32. Thompson JA, Glasgow LA, Warpinski JR, Olson C. Infant botulism: clinical spectrum and epidemiology. Pediatrics 1980; 66: 936-42.
33. Long SS, Gajewski JL, Brown LW, Gilligan PH. Clinical, laboratory, and environmental features of infant botulism in Southeastern Pennsylvania. Pediatrics 1985; 75: 935-41.
34. Underwood K, Rubin S, Deakers T, Newth C. Infant botulism: a 30-year experience spanning the introduction of botulism immune globulin intravenous in the intensive care unit at childrens Hospital Los angeles. Pediatrics 2007; 120: e1380-5.
35. Thompson JA, Filloux FM, Van Orman CB, Swoboda K, Peterson P, Firth SD, Bale JF, Jr. Infant botulism in the age of botulism immune globulin. Neurology 2005; 64: 2029-32.
36. Arnon SS, Midura TF, Damus K, Thompson B, Wood RM, Chin J. Honey and other environmental risk factors for infant botulism. J Pediatr 1979; 94: 331-6.
37. Dodds KL. Worlwide incidence and ecology of infant botulism. In: Hauschild AH, Dodds KL (ed). Ecology and Control food. New York: Marcel Dekker, Inc; 1992. p. 105-20.
38. Austin J. Botulism in Canada - summary for 1995. Can Commun Dis Rep 1996; 22: 182-3.
39. European Commision. Opinion of the scientific committee on veterinary measures relating to public health on honey and microbiological hazards. Adopted on 19-20 June 2002. EC; 2002.
40. Brett MM, McLauchlin J, Harris A, O'Brien S, Black N, Forsyth RJ, Roberts D, Bolton FJ. A case of infant botulism with a possible link to infant formula milk powder: evidence for the presence of more than one strain of Clostridium botulinum in clinical specimens and food. J Med Microbiol 2005; 54 (Pt 8): 769-76.
41. Johnson EA, Tepp WH, Bradshaw M, Gilbert RJ, Cook PE, McIntosh ED. Characterization of Clostridium botulinum strains associated with an infant botulism case in the United Kingdom. J Clin Microbiol 2005; 43: 2602-7.
42. Bianco MI, Luquez C, de Jong LI, Fernandez RA. Presence of Clostridium botulinum spores in Matricaria chamomilla (chamomile) and its relationship with infant botulism. Int J Food Microbiol 2008; 121: 357-60.
43. Cardenas Aranzana MJ, Isla Tejera B, Gil Navarro MV, Lopez Laso E. Botulismo infantil tratado con inmunoglobulina botulinica humana. Farm Hosp 2007; 31: 379-87.
44. Ahsan CR, Hajnoczky G, Maksymowych AB, Simpson LL. Visualization of binding and transcytosis of botulinum toxin by human intestinal epithelial cells. J Pharmacol Exp Ther 2005; 315: 1028-35.
45. Simpson LL. Identification of the major steps in botulinum toxin action. Annu Rev Pharmacol Toxicol 2004; 44: 167-93.
46. Hauschild AH. Clostridium botulinum toxins. Int J Food Microbiol 1990; 10: 113-24.
47. Sugiyama H, Mills DC. Intraintestinal toxin in infant mice challenged intragastrically with Clostridium botulinum spores. Infect Immun 1978; 21: 59-63.
48. Burr DH, Sugiyama H. Susceptibility to enteric botulinum colonization of antibiotic-treated adult mice. Infect Immun 1982; 36: 103-6.
49. Miyazaki S, Sakaguchi G. Experimental botulism in chickens: the cecum as the site of production and absorption of botulinum toxin. Jpn J Med Sci Biol 1978; 31: 1-15.
50. Mills DC, Arnon SS. The large intestine as the site of Clostridium botulinum colonization in human infant botulism. J Infect Dis 1987; 156: 997-8.
51. Peterson DR, Eklund MW, Chinn NM. the sudden infant death syndrome and infant botulism. Rev Infect Dis 1979; 1: 630-6.
52. Arnon SS, Midura TF, Clay Sa, Wood RM, Chin J. Infant botulism. Epidemiological, clinical, and laboratory aspects. Jama 1977; 237: 1946-51.
53. Yoshioka H, Iseki K, Fujita K. Development and differences of intestinal fora in the neonatal period in breast-fed and bottle-fed infants. Pediatrics 1983; 72: 317-21.
54. Cochetiere de La MF, Rouge C, Darmaun D, Roze JC, Potel G, Leguen CL. Intestinal microbiota in neonates and preterm Infants: A Review. Current Pediatrics Reviews 2007; 3: 21-34.
55. CDC. A case of infant botulism. Commun Dis Rep CDR Wkly 1994; 4:53.
56. Rick JR, Ascher DP, Smith RA. Infantile botulism: an atypical case of an uncommon disease. Pediatrics 1999; 103 (5 Pt. 1): 1038-9.
57. Midura T F. Update: infant botulism. Clin Microbiol Rev 1996; 9: 119-25.
58. Arnon SS, Damus K, Chin J. Infant botulism: epidemiology and relation to sudden infant death syndrome. Epidemiol Rev 1981; 3: 45-66.
59. Sonnabend OA, Sonnabend WF, Krech U, Molz G, Sigrist T. Continuous microbiological and pathological study of 70 sudden and unexpected infant deaths: toxigenic intestinal clostridium botulinum infection in 9 cases of sudden infant death syndrome. Lancet 1985; 1: 237-41.
60. Aureli P, Ferrini AM. Identification of C. botulinum spores in a case of sudden infant death in Italy. Description of a clinical case. Minerva Pediatr 1988; 40: 125-6.
61. Bohnel H, Behrens S, Loch P, Lube K, Gessler F. Is there a link between infant botulism and sudden infant death? Bacteriological results obtained in central Germany. Eur J Pediatr 2001; 160: 623-8.
62. Nevas M, Lindstrom M, Virtanen A, Hielm S, Kuusi M, Arnon SS, Vuori E, Korkeala H. Infant botulism acquired from household dust presenting as sudden infant death syndrome. J Clin Microbiol 2005; 43: 511-3.
63. Byard RW, Moore L, Bourne AJ, Lawrence AJ, Goldwater PN. Clostridium botulinum and sudden infant death syndrome: a 10 year prospective study. J Paediatr Child Health 1992; 28: 156-7.
64. Eleopra R, Tugnoli V, Rossetto O, De Grandis D, Montecucco C. Different time courses of recovery after poisoning with botulinum neurotoxin serotypes a and e in humans. Neurosci Lett 1998; 256: 135-8.
65. Foran PG, Mohammed N, Lisk GO, Nagwaney S, Lawrence GW, Johnson E, Smith L, Aoki KR, Dolly JO. Evaluation of the therapeutic usefulness of botulinum neurotoxin B, C1, E, and F compared with the long lasting type A. Basis for distinct durations of inhibition of exocytosis in central neurons. J Biol Chem 2003; 278: 1363-71.
66. Hatheway CL, McCroskey LM. Examination of feces and serum for diagnosis of infant botulism in 336 patients. J Clin Microbiol 1987; 25: 2334-8.
67. Oguma K, Yokota K, Hayashi S, Takeshi K, Kumagai M, Itoh N, Tachi N, Chiba S. Infant botulism due to Clostridium botulinum type c toxin. Lancet 1990; 336: 1449-50.
68. Gottlieb SL, Kretsinger K, Tarkhashvili N, Chakvetadze N, Chokheli M, Chubinidze M, Michael Hoekstra R, Jhorjholiani E, Mirtskhulava M, Moistsrapishvili M, Sikharulidze M, Zardiashvili T, Imnadze P, Sobel J. Long-term outcomes of 217 botulism cases in the Republic of Georgia. Clin Infect Dis 2007; 45: 174-80.
69. Glauser TA, Maguire HC, Sladky JT. Relapse of infant botulism. Ann Neurol 1990; 28: 187-9.
70. Ravid S, Maytal J, Eviatar L. Biphasic course of infant botulism. Pediatr Neurol 2000; 23: 338-9.
71. Fenicia L, Da Dalt L, Anniballi F, Franciosa G, Zanconato S, Aureli P. A case if infant botulism due to neurotoxigenic Clostridium butyricum type e associated with Clostridium difficile colitis. Eur J Clin Microbiol Infect Dis 2002; 21: 736-8.
72. Arnon SS, Schechter R, Maslanka Se, Jewell NP, Hatheway CL. Human botulism immune globulin for the treatment of infant botulism. N Engl J Med 2006; 354: 462-71.
73. Kobayashi H, Fujisawa K, Saito Y, Kamijo M, Oshima S, Kubo M, Eto Y, Monma C, Kitamura M. A botulism case of a 12-year-old girl caused by intestinal colonization of Clostridium botulinum type ab. Jpn J Infect Dis 2003; 56: 73-4.
74. Schreiner MS, Field E, Ruddy R. Infant botulism: a review of 12 years' experience at the children's Hospital of Philadelphia. Pediatrics 1991; 87: 159-65.
75. Kakava FV, Papazoglou KG, Sideri GI, JH P. Severe infant botulism with cardiac arrest. J Pediatric Neurol 2005; 5: 175-17.
76. Kurland G, Seltzer J. Antidiuretic hormone excess in infant botulism. Am J Dis Child 1987; 141: 1227-9.
77. Sobel J, Malavet M, John S. Outbreak of clinically mild botulism type e illness from home-salted fsh in patients presenting with predominantly gastrointestinal symptoms. Clin Infect Dis 2007; 45: e14-6.
78. Mitchell WG, Tseng-Ong L. Catastrophic presentation of infant botulism may obscure or delay diagnosis. Pediatrics 2005; 116: e436-8.
79. Schechter R, Peterson B, McGee J, Idowu O, Bradley J. Clostridium difficile colitis associated with infant botulism: near-fatal case analogous to Hirschsprung's enterocolitis. Clin Infect Dis 1999; 29: 367-74.
80. th Annual Interagency Botulism Research Coordinating Committee (IBRCC) Meeting. Philadelphia, PA, USA, 14-18 September 2008; p. 5.
81. Taylor S. Infant botulism in a 10-week-old male: a wolf in sheep's clothing. J Emerg Nurs 2002; 28: 581-3.
82. Johnson RO, Clay SA, Arnon SS. Diagnosis and management of infant botulism. Am J Dis Child 1979; 133: 586-93.
83. Gutierrez AR, Bodensteiner J, Gutmann L. Electrodiagnosis of infantile botulism. J Child Neurol 1994; 9: 362-5.
84. Padua L, Aprile I, Monaco ML, Fenicia L, Anniballi F, Pauri F, Tonali P. Neurophysiological assessment in the diagnosis of botulism: usefulness of single-fiber EMG. Muscle Nerve 1999; 22: 1388-92.
85. Long SS. Infant botulism and treatment with BIG-IV (BabyBIG). Pediatr Infect Dis J 2007; 26: 261-2.
86. Francisco AM, Arnon SS. clinical mimics of infant botulism. Pediatrics 2007; 119: 826-8.
87. Wilcke BW, Jr., Midura TF, Arnon SS. Quantitative evidence of intestinal colonization by Clostridium botulinum in four cases of infant botulism. J Infect Dis 1980; 141: 419-23.
88. CDC. Botulism case definition. MMWR 1997; 46 (RR10) (May 02): 1-55.
89. CDC. Botulism in United States, 1899-1966. Handbook for epidemiologists, clinical and laboratory workers. Center for diseases control and prevention; Atlanta: CDC; 1998.
90. Lindstrom M, Keto R, Markkula A, Nevas M, Hielm S, Korkeala H. Multiplex PCR assay for detection and identification of Clostridium botulinum types A, B, E, and F in food and fecal material. Appl Environ Microbiol 2001; 67: 5694-9.
91. Fach P, Micheau P, Mazuet C, Perelle S, Popoff M. Development of real-time PCR tests for detecting botulinum neurotoxins A, B, E, F producing Clostridium botulinum, Clostridium baratii and Clostridium butyricum. J Appl Microbiol 2009.
92. Fernandez RA, Ciccarelli AS, de centorbi ONP, Centorbi H, Rosetti FA, de Jong L, Demo L. Infant botulism in argentina. J Anaerobe 1999; 5: 177-9.
93. Brook I. Infant botulism. J Perinatol 2007; 27: 175-80.
94. L'Hommedieu C, Stough R, Brown L, Kettrick R, Polin R. Potentiation of neuromuscular weakness in infant botulism by aminoglycosides. J Pediatr 1979; 95: 1065-70.
95. Fenicia L, Ferrini AM, Anniballi F, Mannoni V, Aureli P. Considering the antimicrobial sensitivity of the intestinal botulism agent Clostridium butyricum when treating concomitant infections. Eur J Epidemiol 2003; 18: 1153-4.
96. Ong LT, Mitchell WG. Infant botulism: 20 years' experience at a single institution. J Child Neurol 2007; 22: 1333-7.
97. WHO. Clostridium Botulinum. Geneva: WHO; 2002.
98. Agostoni C, Axelsson I, Braegger C, Goulet O, Koletzko B, Michaelsen KF, Rigo J, Shamir R, Szajewska H, Turck D, Weaver LT. Probiotic bacteria in dietetic products for infants: a commentary by the ESPGHAN committee on Nutrition. J Pediatr Gastroenterol Nutr 2004; 38: 365-74.
99. Armada M, Love S, Barrett e, Monroe J, Peery D, Sobel J. Foodborne botulism in a six-month-old infant caused by home-canned baby food. Ann Emerg Med 2003; 42: 226-9.
100. Berkes A, Szegedi I, Szikszay E, Gulyas M, Olah E. Botulism in infancy-survey of literature based on a case report. Orv Hetil 2007; 148: 1117-25.
101. Paerregaard A, Angen O, Lisby M, Molbak K, Clausen M. Denmark: Botulism in an infant or infant botulism? Euro Surveill 2008;13(51).
102. Fenicia L, Anniballi F, Aureli P. Human botulism in Italy, 1984-2007. In: Proceeding of Clostridium botulinum-epidemiology, diagnosis, genetics, control and prevention. Helsinki, Finland, 16-19 June 2008; p. 72.
103. th Annual interagency botulism Research Coordinating Committee (IBRCC) meeting. Philadelphia, Pa, USa, 14-18 September 2008; p. 22.
104. th Annual interagency botulism Research Coordinating Committee (IBRCC) meeting. Asilomar, CA, USA, 14-18 October 2007; p. 29.
105. Grant K. Improved diagnosis of infant botulism by real time PCR of neurotoxin genes. In Proceeding of Clostridium botulinum-epidemiology, diagnosis, genetics, control and prevention. Helsinki. Finland, 16-19 June 2008; p 31.
106. th International conference on basic and therapeutic aspects of botulinum and tetanus toxins; Baveno, Lake Maggiore, Italy, 12-14 June 2008.